§ 330.11. NDA deviations from applicable monograph.
83 words·~1 min read·
/us/cfr/t21/s§ 330.11·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
A new drug application requesting approval of an OTC drug deviating in any respect from a monograph that has become final shall be in the form required by § 314.50 of this chapter, but shall include a statement that the product meets all conditions of the applicable monograph except for the deviation for which approval is requested and may omit all information except that pertinent to the deviation. [39 FR 11741, Mar. 29, 1974, as amended at 55 FR 11581, Mar. 29, 1990]
Connections8 cite this
Cited by 8 sections
register
- Proposed RulesFinal rule
- Proposed RulesAdvance notice of proposed rulemaking; request for data and information
- Rules and RegulationsCorrecting amendments
- NoticesNotice of availability; request for comment
- Rules and RegulationsProposed rule
- Rules and RegulationsProposed rule
- UnknownFinal special conditions
- Rules and RegulationsProposed rule
Citation graph
cites case law
§ 330.11
NDA deviations from applicable monograph.
Fed. Reg.×8
Cites 0Cited by 8 across 1 source